The Quantellect read.As of Nov 19, 2026, 4 active firms cover Afya Ltd: 1 rate it Buy or better, 2 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $16.00 to $19.00, so the covering firms are broadly aligned. The average target of $17.00 sits 68% above the current $10.12. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 0 to 1 over recent months. On the fundamentals, the Street sees revenue growth near 8% this year and 7% next, consensus EPS building from about $3.59 next quarter toward $10.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Neutral
Strong Buy00%
Buy125%
Neutral250%
Sell125%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$17.00
+68.0% upside
Average target across 4 active firms as of Nov 19, 2026 vs $10.12 current
Highest Target$19.00
Average Target$17.00
Lowest Target$16.00
Detailed analyst forecasts for AFYA
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 1 of 4 active firms rate AFYA a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AFYA EPS & revenue forecast
EPS · NEXT QUARTER
$3.59
Range $3.59 – $3.59 · 1 analysts · +26% YoY
Next period, 1 analysts expect Afya Ltd to earn $3.59 a share (range $3.59 – $3.59), versus $2.85 a year earlier. Full-year consensus is $9.27, growing to $10.08 the year after.
REVENUE · NEXT QUARTER
$1.1B
Range $1.1B – $1.1B · 1 analysts · +9% YoY
Revenue is expected to reach $1.1B (range $1.1B – $1.1B), +9.0% year-over-year. Full-year consensus is $4.0B, rising to $4.2B next year.
Top analysts covering Afya Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AFYA.
#1
MS
Marcelo Santos
JP Morgan
Buy
$19.00+87.7% to target
Coverage
—
+ Follow
#2
AS
Andre Salles
UBS
Neutral
$16.00+58.1% to target
Coverage
—
+ Follow
#3
LB
Leandro Bastos
Citigroup
Neutral
$14.00+38.3% to target
Coverage
—
+ Follow
#4
MC
Mauricio Cepeda
Morgan Stanley
Sell
$16.00+58.1% to target
Coverage
—
+ Follow
#5
RO
Roberto Otero
B of A Securities
Neutral
$17.00+68.0% to target
Coverage
—
+ Follow
AFYA stock forecast FAQ
What is AFYA's average 12-month price target?+
The 4 active firms with a live target average $17.00 for Afya Ltd over the next 12 months, ranging from a $19.00 high to a $16.00 low, as of Nov 19, 2026.
Is AFYA stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 4 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 2 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AFYA?+
The Street-high target is $19.00 (JP Morgan), and the Street-low is $16.00 (Morgan Stanley). The average of all 4 active-firm targets is $17.00.
How many active Wall Street firms cover AFYA?+
4 active firms have a recognized rating on Afya Ltd as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AFYA?+
Among analysts who currently cover AFYA, Marcelo Santos of JP Morgan has the strongest overall Quantellect track record. Their current call is Buy with a $19.00 target.
What is Afya Ltd's projected EPS for next quarter?+
The consensus estimate is $3.59 per share (range $3.59 – $3.59) across 1 analysts. Full-year EPS is projected at $9.27, rising to $10.08 the following year.
How much revenue is Afya Ltd expected to report next quarter?+
Consensus revenue is $1.1B (range $1.1B – $1.1B). Full-year revenue is projected at $4.0B, growing to $4.2B next year.
Have analysts been upgrading or downgrading AFYA lately?+
As of Nov 19, 2026, 1 of 4 active firms rate AFYA a Buy (2 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AFYA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.